4.7 Article

Neocryptotanshinone ameliorates insufficient energy production in heart failure by targeting retinoid X receptor alpha

Related references

Note: Only part of the references are listed.
Article Plant Sciences

Neocryptotanshinone protects against myocardial ischemia-reperfusion injury by promoting autolysosome degradation of protein aggregates via the ERK1/2-Nrf2-LAMP2 pathway

Ye Yang et al.

Summary: This study investigated the therapeutic effect and mechanism of Neocryptotanshinone (NCTS) on myocardial ischemia/reperfusion (I/R) injury. The results showed that NCTS promoted autolysosome removal of protein aggregates through the upregulation of the ERK1/2-Nrf2-LAMP2 signaling pathway, leading to cardiac protection in I/R. NCTS also limited oxidative stress and cellular apoptosis.

PHYTOMEDICINE (2023)

Article Immunology

Mechanism of neocryptotanshinone in protecting against cerebral ischemic injury: By suppressing M1 polarization of microglial cells and promoting cerebral angiogenesis

Liping Zhai et al.

Summary: This study explored the protective function and mechanism of neocryptotanshinone (NEO) on cerebral ischemia. The results showed that NEO suppressed M1 polarization of microglial cells through inhibiting NF-Kappa B and STAT3 signals, thereby reducing the levels of inflammatory factors. NEO also promoted cerebral angiogenesis by activating the VEGF-VEGFR2-Notch1 signal in hypoxic conditions. Moreover, NEO demonstrated protective effects against cerebral ischemia in mice by improving neurological behaviors and decreasing inflammatory factors.

INTERNATIONAL IMMUNOPHARMACOLOGY (2023)

Article Nutrition & Dietetics

The Antidiabetic Activities of Neocryptotanshinone: Screened by Molecular Docking and Related to the Modulation of PTP1B

Jie Hao et al.

Summary: The aim of this study was to provide a practical experimental basis for the development of Neocryptotanshinone (NCTS) as an effective hypoglycemic drug and a theoretical method for the rapid screening of natural compounds with hypoglycemic effects. The results demonstrated that NCTS effectively lowered blood glucose in db/db mice by regulating the expression of PTP1B in the liver and muscle.

NUTRIENTS (2022)

Article Biochemistry & Molecular Biology

The role of the retinoid receptor, RAR/RXR heterodimer, in liver physiology

Baixue Li et al.

Summary: Retinoic acid receptors (RARs) and retinoid X receptors (RXRs), activated by retinoids, play crucial roles in various biological processes such as embryo development, homeostasis, cell proliferation, differentiation and death. In liver physiology, RAR/RXR heterodimers regulate lipid and bile acid synthesis and metabolism, cholesterol transport in macrophages, and fibrogenesis in hepatic stellate cells. Specific genes carrying out these functions are regulated by RAR/RXR in liver cells, providing a mechanistic understanding of their roles in liver physiology. Still, detailed signaling mechanisms of RAR/RXR in regulating liver gene expression remain to be fully elucidated in future studies.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2021)

Article Plant Sciences

Exploring the protective effects of PNS on acute myocardial ischaemia-induced heart failure by Transcriptome analysis

Xu Chen et al.

Summary: The study confirmed the cardioprotective effects of PNS and its involvement in metabolic processes through the PPAR signaling pathway in HF treatment. PNS was found to upregulate genes, particularly those related to energy metabolism, and the PPAR alpha pathway was identified as a key mechanism for the protective function of PNS. The inhibition of PPAR alpha abolished the beneficial effects of PNS, suggesting that PPAR alpha may be a potential target for HF treatment.

JOURNAL OF ETHNOPHARMACOLOGY (2021)

Review Medicine, Research & Experimental

The multi-faceted role of retinoid X receptor in cardiovascular diseases

Mingyan Shao et al.

Summary: RXRs play a crucial role in heart development and energy metabolism. While they are promising targets for treating cardiovascular diseases, their use is limited by toxicity. Further understanding of the mechanisms of RXRs in cardiovascular disease can aid in the rational design of more selective drugs.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Article Cardiac & Cardiovascular Systems

Cardiac Energy Metabolism in Heart Failure

Gary D. Lopaschuk et al.

Summary: Changes in cardiac energy metabolism are complex and depend on the severity and type of heart failure, as well as the presence of common comorbidities such as obesity and type 2 diabetes. The failing heart experiences an energy deficit due to decreased mitochondrial oxidative capacity, compensated for by increased ATP production from glycolysis. Alterations in mitochondrial ATP production fuels and fatty acid oxidation contribute to the inefficiency of the failing heart, with potential therapeutic targets in energy metabolic pathways to improve cardiac function.

CIRCULATION RESEARCH (2021)

Article Cell Biology

Salvia miltiorrhiza and the Volatile of Dalbergia odorifera Attenuate Chronic Myocardial Ischemia Injury in a Pig Model: A Metabonomic Approach for the Mechanism Study

Rui Lin et al.

Summary: Metabonomic method based on HPLC-Q-TOF-MS was utilized to evaluate the effects of SM-DOO on chronic myocardial ischemia. The study revealed that SM-DOO can regulate biomarkers and metabolic pathways related to energy metabolism and glucose metabolism, especially by upregulating p-AMPK and GLUT4 protein expressions. This indicates a potential cardioprotective mechanism of SM-DOO in chronic myocardial ischemia.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)

Article Pharmacology & Pharmacy

A Retinoic Acid Receptor β2 Agonist Improves Cardiac Function in a Heart Failure Model

Xiao-Han Tang et al.

Summary: AC261066 attenuates post-MI cardiac dysfunction and maladaptive remodeling by modulating a set of genes involved in oxidant/antioxidant balance. This suggests that RAR beta(2) could be a potential pharmacological target for the treatment of HF, as MI is a major cause of this condition.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2021)

Review Cardiac & Cardiovascular Systems

PPAR control of metabolism and cardiovascular functions

David Montaigne et al.

Summary: Novel PPAR agonists offer new opportunities for managing metabolic and cardiovascular diseases by regulating gene expression, lipid metabolism, insulin sensitivity, glucose metabolism, and cardiovascular health. Activation of PPARs by specific ligands can have antiatherogenic, anti-inflammatory, and metabolic benefits, making them important therapeutic targets in the treatment of various diseases.

NATURE REVIEWS CARDIOLOGY (2021)

Article Medicine, Research & Experimental

Tanshinone IIA protects against heart failure post-myocardial infarction via AMPKs/mTOR-dependent autophagy pathway

Xuefeng Zhang et al.

BIOMEDICINE & PHARMACOTHERAPY (2019)

Article Medicine, Research & Experimental

Ginsenoside Rb3 regulates energy metabolism and apoptosis in cardiomyocytes via activating PPARα pathway

Xu Chen et al.

BIOMEDICINE & PHARMACOTHERAPY (2019)

Article Biochemistry & Molecular Biology

KDM3A Senses Oxygen Availability to Regulate PGC-1α-Mediated Mitochondrial Biogenesis

Xu Qian et al.

MOLECULAR CELL (2019)

Review Pharmacology & Pharmacy

Cardiac metabolism - A promising therapeutic target for heart failure

Hannah Noordali et al.

PHARMACOLOGY & THERAPEUTICS (2018)

Review Biochemistry & Molecular Biology

Retinoid X Receptor Antagonists

Masaki Watanabe et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Review Medicine, Research & Experimental

Mitochondrial dysfunction in pathophysiology of heart failure

Bo Zhou et al.

JOURNAL OF CLINICAL INVESTIGATION (2018)

Review Biochemistry & Molecular Biology

Structural basis of mitochondrial transcription

Hauke S. Hillen et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)

Review Biochemistry & Molecular Biology

Elucidating the Beneficial Role of PPAR Agonists in Cardiac Diseases

Zaza Khuchua et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Review Cardiac & Cardiovascular Systems

Metabolic Modulators in Heart Disease: Past, Present, and Future

Gary D. Lopaschuk

CANADIAN JOURNAL OF CARDIOLOGY (2017)

Article Cardiac & Cardiovascular Systems

Mitochondrial pathways to cardiac recovery: TFAM

George H. Kunkel et al.

HEART FAILURE REVIEWS (2016)

Article Biochemical Research Methods

Comparing sixteen scoring functions for predicting biological activities of ligands for protein targets

Weijun Xu et al.

JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2015)

Article Biochemistry & Molecular Biology

Nuclear Receptors, RXR, and the Big Bang

Ronald M. Evans et al.

Review Cardiac & Cardiovascular Systems

Cardiac Metabolism in Heart Failure Implications Beyond ATP Production

Torsten Doenst et al.

CIRCULATION RESEARCH (2013)

Review Cardiac & Cardiovascular Systems

An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy

Xavier Palomer et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)

Article Biochemistry & Molecular Biology

PubChem's BioAssay Database

Yanli Wang et al.

NUCLEIC ACIDS RESEARCH (2012)

Review Peripheral Vascular Disease

Retinoid X Receptor Heterodimer Variants and Cardiovascular Risk Factors

Atsushi Nohara et al.

JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2009)

Article Multidisciplinary Sciences

A transcriptionally silent RXRα supports early embryonic morphogenesis and heart development

Benedicte Mascrez et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Review Medicine, Research & Experimental

The PPAR alpha-PGC-1 alpha Axis Controls Cardiac Energy Metabolism in Healthy and Diseased Myocardium

Jennifer G. Duncan et al.

PPAR RESEARCH (2008)

Article Peripheral Vascular Disease

On the hypothesis that the failing heart is energy starved: Lessons learned from the metabolism of ATP and creatine

Joanne S. Ingwall

CURRENT HYPERTENSION REPORTS (2006)